If nuclear disaster strikes, U.S. hematologists stand readyJuly 8, 2022Mixed TopicsTransplantPatient & Survivor Care
Doc releases song after racist massacre in BuffaloJuly 7, 2022Diversity in MedicineMixed TopicsBusiness of Medicine
‘Superior’ CLL regimen cuts chemo in halfJune 28, 2022CLLCellular TherapyMixed TopicsGene TherapyMyelodysplastic SyndromeAML
FDA approves liso-cel as second-line therapy for LBCLJune 27, 2022B Cell LymphomaMixed TopicsCellular TherapyGene TherapyCLL
‘My malpractice insurance doubled!’ Why, when fewer patients are suing?June 10, 2022Business of MedicineMixed Topics
Novel gene therapy offers hope for some lymphomasJune 9, 2022B Cell LymphomaGene TherapyTransplantMixed Topics
‘Extremely exciting’ study results guide MM treatment optionsJune 6, 2022Multiple MyelomaTransplantAMLMyelodysplastic SyndromeMixed Topics
Surgical site infections not increased in immunocompromised patients after Mohs surgeryJune 6, 2022Mixed Topics
